trending Market Intelligence /marketintelligence/en/news-insights/trending/Iv1RDPO5UfO-vxbeHvrjQw2 content esgSubNav
In This List

Mach7 Technologies to sell 3D medical business, names COO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Mach7 Technologies to sell 3D medical business, names COO

Mach7 Technologies Ltd. decided to sell its 3D medical business, citing a competitive environment and less-than-expected synergies.

The divestiture will enable Mach7 Technologies to focus on its enterprise imaging business. Further, the divestment and other initiatives will allow the company to book annual cost savings of at least A$1.2 million.

Separately, the company appointed Mike Lampron COO. Lampron was most recently vice president, services, at iCAD Inc.